| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2026―Feb―28 |
Metabolism-dependent endocrine regulation of TMPRSS2 gene expression (rs12329760): proteomic networks and functional pathways of interaction in COVID-19","Метаболізмзалежна ендокринна регуляція експресії гена TMPRSS2 (rs12329760): протеомні мережі та функціональні шляхи взаємодії при COVID-19 |
L. Sydorchuk, M. Sokolenko, V. Vasiuk, V. Dzhuryak, A. Gutnitska, L. Honcharuk, et al. (+2) D. Sobko, Y. Karavan |
| 2 |
[GO] |
2025―Sep―29 |
Post COVID-19 structural, functional and immune changes of the thyroid in patients with autoimmune thyroiditis |
Yu.V. Buldygina, A.H. Haletska, H.M. Terekhova, S.L. Shlyakhtych, Yu.I. Belyakova |
| 3 |
[GO] |
2025―Jan―04 |
Study of cardiovascular risk in type 2 diabetic patients in the acute phase of the coronavirus infection and post-COVID period on the background of therapy with sodium-glucose cotransporter-2 inhibitors |
N.M. Kushnarоva, O.V. Zinych, A.A. Shuprovych, K.P. Komisarenko |
| 4 |
[GO] |
2024―Sep―27 |
The effect of COVID-19 on the presentation of thyroid antibodies. Case report |
Afrim Zeqiraj |
| 5 |
[GO] |
2024―Jan―09 |
Erectile function in men with COVID-19 six months after recovery |
E.V. Luchytskyi, V.E. Luchytskyi, G.A. Zubkova, V.M. Rybalchenko, I.I. Skladanna |
| 6 |
[GO] |
2023―Oct―31 |
Diabetes mellitus and COVID-19: living with double risk |
O.V. Muravlova, Z.O. Shaienko, I.L. Dvornyk, L.M. Sizova, V.I. Ilchenko, T.I. Purdenko, O.A. Shpetnyi |
| 7 |
[GO] |
2023―Apr―29 |
Hyporeninemic hypoaldosteronism as a manifestation of autonomic neuropathy in a patient with type 2 diabetes mellitus against the background of coronavirus disease. A clinical case |
N.O. Pertseva, T.V. Chursinova, A.A. Gryshniakova |
| 8 |
[GO] |
2022―Oct―11 |
Why is the mortality rate high in RT-PCR negative COVID-19 patients with comorbid diseases? |
Mümtaz Taner Torun, Dilber Yilmaz Durmaz |
| 9 |
[GO] |
2022―Apr―22 |
Hypercortisolism on the background of recovery of COVID-19 (сase report) |
V. Kravchenko, O. Rakov, L.V. Slipachuk |
| 10 |
[GO] |
2021―Oct―29 |
Treatment of neurological complications in patients with type 2 diabetes mellitus at the stage of rehabilitation after COVID-19 |
V.I. Pankiv |
| 11 |
[GO] |
2021―Oct―20 |
Effects of COVID-19 and diabetes mellitus on apolipoprotein A1 level in the blood plasma of patients |
V.V. Pushkarev, L.K. Sokolova, S.A. Cherviakova, Yu.B. Belchina, M.V. Bigun, O.I. Kovzun, et al. (+2) V.M. Pushkarev, M.D. Tronko |
| 12 |
[GO] |
2021―Oct―20 |
Diabetic ketoacidosis precipitated by COVID-19 in patient with newly diagnosed diabetes mellitus |
E. Xhardo, P. Kapisyzi, A. Rada |
| 13 |
[GO] |
2021―Aug―20 |
Pathophysiological and clinical aspects of interaction between coronavirus disease 2019 and thyroid |
V.I. Pankiv, N.V. Pashkovska, I.V. Pankiv, V.A. Maslyanko, I.O. Tsaryk |
| 14 |
[GO] |
2021―May―14 |
Compliance to levothyroxine treatment of the patients with hypothyroidism during SARS-CoV-2 pandemic era |
Satilmis Bilgin, Burcin Meryem Atak Tel, Tuba Taslamacioglu Duman, Ozge Kurtkulagi, Gizem Bakir Kahveci, Tugrul Sagdic, Gulali Aktas |
| 15 |
[GO] |
2021―Apr―06 |
Clinical characteristics of covid-19 patients at King Saud Medical City: a retrospective study |
Marwah Bin Talib, Abdullah A. Baredhwan, Khaled Alenazi, Ali Almagooshi, Abdulrehman M. Alqahtani, Sultan A. Alsobayeg, et al. (+6) Sarah Alhazmi, Waad Awad, Ameera S. Alamri, Parameaswari P. Jaganathan, Manasik N. Abdu, Latif Ahmed Khan |
| 16 |
[GO] |
2020―Dec―29 |
COVID-19: a new etiological factor of Graves’ disease? |
A.M. Urbanovych, F.V. Laniush, O.Z. Lishchuk, K.Yu. Kozlovska |
| 17 |
[GO] |
2020―Aug―28 |
COVID-19 and diabetes mellitus: management of patients during the pandemic |
N.V. Pashkovska, V.I. Pankiv, O.V. Pashkovska |
